Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05509439 · ClinicalTrials.gov registry record · NA
Home Transfusion for HEME
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05509439 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants.
The verdict
NCT05509439, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of the research is to assess the feasibility and acceptability of a home blood transfusion program for patients with hematologic malignancies who need blood transfusions
Interventions
- OTHER Home Transfusion Program Components
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-10-18 |
| Est. Completion | 2025-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05509439
The ClinicalTrials.gov registry entry for NCT05509439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home Transfusion Program Components is the first listed.
NCT05509439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05509439 about?
NCT05509439 is a clinical study titled "Home Transfusion for HEME". The purpose of the research is to assess the feasibility and acceptability of a home blood transfusion program for patients with hematologic malignancies who need blood transfusions
What is the current status of trial NCT05509439?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-10-18. Estimated completion is 2025-05-21.
What interventions are being tested in trial NCT05509439?
The interventions under investigation include: Home Transfusion Program Components (OTHER).
Who is sponsoring clinical trial NCT05509439?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.